-
Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA
Van Der Pol, Y. & Mouliere, F., 14 Oct 2019, In: Cancer cell. 36, 4, p. 350-368 19 p.Research output: Contribution to journal › Review article › Academic › peer-review
-
Enhanced detection of circulating tumor DNA by fragment size analysis
Mouliere, F., Chandrananda, D., Piskorz, A. M., Moore, E. K., Morris, J., Ahlborn, L. B., Mair, R., Goranova, T., Marass, F., Heider, K., Wan, J. C. M., Supernat, A., Hudecova, I., Gounaris, I., Ros, S., Jimenez-Linan, M., Garcia-Corbacho, J., Patel, K., Østrup, O., Murphy, S., & 17 others , 7 Nov 2018, In: Science Translational Medicine. 10, 466Research output: Contribution to journal › Article › Academic › peer-review
-
Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients
Mouliere, F., Mair, R., Chandrananda, D., Marass, F., Smith, C. G., Su, J., Morris, J., Watts, C., Brindle, K. M. & Rosenfeld, N., 1 Dec 2018, In: EMBO molecular medicine. 10, 12, e9323.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
-
Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis
Moldovan, N., van der Pol, Y., van den Ende, T., Boers, D., Verkuijlen, S., Creemers, A., Ramaker, J., Vu, T., Bootsma, S., Lenos, K. J., Vermeulen, L., Fransen, M. F., Pegtel, M., Bahce, I., van Laarhoven, H. & Mouliere, F., 16 Jan 2024, In: Cell Reports Medicine. 5, 1, 101349.Research output: Contribution to journal › Article › Academic › peer-review
-
Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing
van der Pol, Y., Tantyo, N. A., Evander, N., Hentschel, A. E., Wever, B. M. M., Ramaker, J., Bootsma, S., Fransen, M. F., Lenos, K. J., Vermeulen, L., Schneiders, F. L., Bahce, I., Nieuwenhuijzen, J. A., Steenbergen, R. D. M., Pegtel, D. M., Moldovan, N. & Mouliere, F., 7 Dec 2023, In: EMBO molecular medicine. 15, 12, e17282.Research output: Contribution to journal › Article › Academic › peer-review
-
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer (Nature Communications, (2022), 13, 1, (3246), 10.1038/s41467-022-30666-0)
Coombes, R. C., Badman, P. D., Lozano-Kuehne, J. P., Liu, X., Macpherson, I. R., Zubairi, I., Baird, R. D., Rosenfeld, N., Garcia-Corbacho, J., Cresti, N., Plummer, R., Armstrong, A., Allerton, R., Landers, D., Nicholas, H., McLellan, L., Lim, A., Mouliere, F., Pardo, O. E., Ferguson, V., & 1 others , 1 Dec 2023, In: Nature communications. 14, 1, 260.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications